Skip to content

Maintaining and imPrOving the intrinSIc capaciTy Involving Primary Care and caregiVErs

POSITIVE: Maintaining and imPrOving the intrinSIc capaciTy Involving Primary Care and caregiVErs

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04592146
Acronym
POSITIVE
Enrollment
150
Registered
2020-10-19
Start date
2020-11-01
Completion date
2021-06-30
Last updated
2021-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frail Elderly Syndrome, Frailty, Frailty Syndrome

Keywords

Frailty, Technology, Home monitoring, Older persons

Brief summary

The POSITIVE platform offers the possibility of unsupervised monitoring of pre-frailty and frailty status in a community setting, to detect the onset of frailty and to assess its evolution. The primary objective of the study is to evaluate whether the POSITIVE system improves frailty in at least 1 point in the Fried's Criteria and 5 points in the FTS-5. This is a multi-centre, non-inferiority, randomized, simple blind and prospective pilot study with a 12-month follow up duration. The study will be carried out in Spain, Sweden and Poland. 150 participants will be randomized into two groups. The control group will receive usual medical care. The intervention group will receive, in addition, the POSITIVE frailty home monitoring and intervention system.

Detailed description

The primary endpoints is to evaluate whether a multimodal intervention supported by the POSITIVE technological ecosystem improves frailty in at least 1 point in Fried's Criteria and 5 points in FTS-5 during a 6-month follow-up period. This objective will be investigated through a multi-centre, non-inferiority, randomized, simple blind and prospective pilot study with an intervention lasting for 6 months. The study will be carried out in Spain, Sweden and Poland. 150 participants (50 per site) will be randomized into two groups. The control group will receive usual medical care. The intervention group will receive, in addition, the POSITIVE frailty home monitoring and intervention system. Both groups will be assessed with the same instruments. This assessment will be conducted at baseline (in the beginning of the trial period), at the middle (month 3) and at the end of the intervention (month 6). A stratified randomization technique will be applied in each of the study groups based on: age group (70-85,\> 85), history of cognitive impairment, history of stroke to guarantee the existence of comparable groups. These factors have been significantly associated with frailty and pre-frailty status (stroke OR =3.11 (1.05-9.18), age, per 1-year OR = 1.14 (1.08-1.21); cognitive impairment OR = 8.37 (4.43-15.83)).

Interventions

DEVICEFrailty multicomponent intervention supported by POSITIVE

This technology mainly consists in a home monitoring kit periodically measuring gait speed, involuntary weight loss and power in the lower limb. Furthermore, through a tablet device, other relevant information (e.g. state of mind, activities of daily living-ADLs, etc.) is collected. The same device is used to enhance communication with the clinical team and follow the tailored intervention

OTHERFrailty multicomponent intervention

This intervention is based on 3 main pillars: medication review (to avoid polypharmacy), tailored nutritional recommendations and a tailored physical activity plan based on the VIVIFRAIL program.

Sponsors

Karolinska Institutet
CollaboratorOTHER
Medical University of Lodz
CollaboratorOTHER
Universidad Politecnica de Madrid
CollaboratorOTHER
KTH Royal Institute of Technology
CollaboratorOTHER
Fundación para la Investigación Biomédica - Hospital Universitario de Getafe
CollaboratorUNKNOWN
Hospital Universitario Getafe
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Multi-centre, non-inferiority, randomized, simple blind and prospective pilot study.

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 70. * Living at home. * Having a caregiver/relative and/or supervision at home. * Barthel ≥ 90. * Meet at least 1 criterion from Fried's Criteria.

Exclusion criteria

* Inadequate home infrastructure to host the required technology. * Inability to understand on how to use the POSITIVE system by the participant. * Diseases that may affect prescription therapy: * History of alcohol/drugs abuse. * Living with another participant. * Participating in other clinical studies. * Three or more hospitalizations in the last year.

Design outcomes

Primary

MeasureTime frameDescription
Frailty status 16 monthsEvaluation of the impact of the technology supported intervention in terms of frailty measured with the Linda Fried's criteria. This test ranges from 0 to 5 (0: robust; 1-2: pre-frailty; +2: frailty).
Frailty status 26 monthsTo evaluate whether a multimodal intervention supported by the POSITIVE technological ecosystem improves frailty in at least 5 points in Frail trait scale (FTS-5) during a 6-month follow-up period. FTS scores between 0-50. 0 is the best value and 50 the worst value.

Secondary

MeasureTime frameDescription
Physical function 16 monthsTo evaluate whether the POSITIVE system improves participants' physical performance according to the Short Physical Performance Battery (SPPB).SPPB scores between 0-12. 0 is the worst and 12 the best value.
Physical function 26 monthsTo evaluate whether the POSITIVE system improves participants' physical performance according to the Gait Speed test (meters/second)
Basic activities daily living (BADL)6 monthsTo evaluate the influence of the POSITIVE system in patients' autonomy every day life (basic activities) according to the Barthel Index. Barthel scores between 0-100; 0 is the worst value and 100 the best.
Disability6 monthsTo evaluate the influence of the POSITIVE system in patients' autonomy every day life (instrumental activities) according to WHO Disability Assessment Schedule (WHODAS 2.0). Score between 0 to 100 (where 0 = no disability; 100 = full disability)
Instrumental activities of daily living (IADL)6 monthsTo evaluate the influence of the POSITIVE system in patients' autonomy every day life (instrumental activities) according to the Lawton and Brody scale. Lawton and Brody scale scores between 0-10; 0 is the worst and 10 the best value.
Frailty trajectories 16 monthsTrajectories of frailty according to changes in Fried´s phenotype. Fried´s Phenotype scores between 0 and 5. 0 means robust; 1-2 mean pre-frail and 3 or more mean frail
Cognitive impairment 16 monthsTo evaluate the influence of the POSITIVE system in the cognitive sphere according to the MONTREAL COGNITIVE ASSESSMENT (MoCA test). Scores between 0-30 being 30 the best value.
Cognitive impairment 26 monthsTo evaluate the influence of the POSITIVE system in the cognitive sphere according to the clock drawing test. Score ranges between 0-10. \<8 suggests that cognitive impairment (CI)
Affective sphere6 monthsTo evaluate the influence of the POSITIVE system in the affective sphere according Geriatric Depression Scale (GDS). Each answer indicating depression (bold 'yes' or 'no) counts one point. Scores greater than 5 are indicative of probable depression. In the experimental site located in Sweden, the version of this scale will be used.
Caregiver quality of life6 monthsTo evaluate the influence of the POSITIVE system on the caregiver quality of life according EuroQoL-5D-5L.
To evaluate the usability of the POSITIVE system according to the System Usability Scale (SUS).6 monthsSUS ranges from 0 to 100. A SUS score above a 68 would be considered above average and anything below 68 is below average..
Health-related quality of life6 monthsTo evaluate the influence of the POSITIVE system in the quality of life according to the European Quality of life 5 dimensions-5 levels (EuroQoL 5D-5L). EuroQoL scores between 0-10 and 10 is the worst quality of life.
Frailty trajectories 26 monthsTo evaluate whether the POSITIVE system improves frailty transitions in pre-frail and frail participants according to FTS-5.

Countries

Poland, Spain, Sweden

Contacts

Primary ContactRodrigo Pérez-Rodríguez, PhD
rprodrigo@salud.madrid.org+34657994364
Backup ContactLeocadio Rodríguez-Mañas, MD, PhD
leocadio.rodriguez@salud.madrid.org

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026